Literature DB >> 23915249

Osteoimmunology and its implications for transplantation.

R Pacifici1.   

Abstract

Osteoimmunology is a field of research dedicated to the study of the interactions between the immune system, the hemopoietic system and bone. Among the cells of the immune system that regulate bone cells and the hemopoietic function are T lymphocytes. These cells secrete inflammatory cytokines that promote bone resorption, as well as Wnt ligands that stimulate bone formation. In addition, T cells regulate bone homeostasis by cross talking with BM stromal cells and osteoblastic cells via CD40 ligand (CD40L) and other costimulatory molecules. This article describes the immune cells relevant to bone and the hemopoietic function, reviews the role of lymphocytes as mediators of the effects of PTH and estrogen in bone and the hemopoietic system and discusses the implication of osteoimmunology for transplant medicine. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Bone; PTH

Mesh:

Substances:

Year:  2013        PMID: 23915249     DOI: 10.1111/ajt.12380

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant.

Authors:  M Pawlowska; Q Yang; B Hamata; D L Kendler; R Broady
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

Review 2.  Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?

Authors:  Baohong Zhao
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 3.  Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia.

Authors:  Rainer H Straub; Maurizio Cutolo; Roberto Pacifici
Journal:  Semin Arthritis Rheum       Date:  2015-04-30       Impact factor: 5.532

4.  Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.

Authors:  Nikolaus Binder; Christine Miller; Masaki Yoshida; Kazuki Inoue; Shinichi Nakano; Xiaoyu Hu; Lionel B Ivashkiv; Georg Schett; Alessandra Pernis; Steven R Goldring; F Patrick Ross; Baohong Zhao
Journal:  J Immunol       Date:  2017-03-17       Impact factor: 5.422

5.  A translational approach from an animal model identifies CD80 as a candidate gene for the study of bone phenotypes in postmenopausal women.

Authors:  L Panach; E Serna; J J Tarín; A Cano; M Á García-Pérez
Journal:  Osteoporos Int       Date:  2017-05-02       Impact factor: 4.507

Review 6.  Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Authors:  Nabanita S Datta
Journal:  Endocrine       Date:  2014-05-07       Impact factor: 3.633

7.  Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.

Authors:  Zhongbo Liu; Tianzhen Han; Haim Werner; Clifford J Rosen; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2017-11-06       Impact factor: 6.741

Review 8.  T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone.

Authors:  Roberto Pacifici
Journal:  Ann N Y Acad Sci       Date:  2015-12-10       Impact factor: 5.691

9.  Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.

Authors:  Sidan Li; Dehui Zou; Changhong Li; Hengxing Meng; Weiwei Sui; Sizhou Feng; Tao Cheng; Qiongli Zhai; Lugui Qiu
Journal:  Stem Cell Res Ther       Date:  2015-09-15       Impact factor: 6.832

10.  Cxcl12 Deletion in Mesenchymal Cells Increases Bone Turnover and Attenuates the Loss of Cortical Bone Caused by Estrogen Deficiency in Mice.

Authors:  Filipa Ponte; Ha-Neui Kim; Srividhya Iyer; Li Han; Maria Almeida; Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2020-03-25       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.